EP1450783A1 - New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma - Google Patents

New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Info

Publication number
EP1450783A1
EP1450783A1 EP02800696A EP02800696A EP1450783A1 EP 1450783 A1 EP1450783 A1 EP 1450783A1 EP 02800696 A EP02800696 A EP 02800696A EP 02800696 A EP02800696 A EP 02800696A EP 1450783 A1 EP1450783 A1 EP 1450783A1
Authority
EP
European Patent Office
Prior art keywords
oxybutynin
delivery system
drug delivery
pharmaceutically acceptable
release composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02800696A
Other languages
German (de)
English (en)
French (fr)
Inventor
Dilip S. SUN PHARMACEUTICAL IND. LTD. SHANGHVI
Ashish P. SUN PHARM. ADVANCED RES. CTR. MUNGRE
Yashoraj R. SUN PHARM. ADVANCED RES. CTR. ZALA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IN2002/000107 external-priority patent/WO2002080887A2/en
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of EP1450783A1 publication Critical patent/EP1450783A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
EP02800696A 2001-10-08 2002-10-08 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma Withdrawn EP1450783A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
INMU09842001 2001-10-08
IN984MU2001 2001-10-08
PCT/IN2002/000107 WO2002080887A2 (en) 2001-04-10 2002-04-09 Timed pulse release composition
WOPCT/IN10/72002 2002-04-09
PCT/IN2002/000203 WO2003030920A1 (en) 2001-10-08 2002-10-08 An antispasmodic agent spaced drug delivery system

Publications (1)

Publication Number Publication Date
EP1450783A1 true EP1450783A1 (en) 2004-09-01

Family

ID=26324117

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02800696A Withdrawn EP1450783A1 (en) 2001-10-08 2002-10-08 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma

Country Status (5)

Country Link
EP (1) EP1450783A1 (zh)
JP (1) JP2005510477A (zh)
CN (1) CN1564691A (zh)
BR (1) BR0213634A (zh)
WO (1) WO2003030920A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5159094B2 (ja) * 2005-11-11 2013-03-06 旭化成ケミカルズ株式会社 活性成分の溶出を徐放性に制御する有核固形製剤
HUE029173T2 (hu) * 2006-04-26 2017-02-28 Alphapharm Pty Ltd Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot
US20080090903A1 (en) * 2006-10-13 2008-04-17 Pandey Ramendra N Phenylalkyl carbamate compositions
GB201003766D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
DE69818607T2 (de) * 1997-05-30 2004-07-29 Osmotica Corp. Mehrlagige osmosevorrichtung
US6248359B1 (en) * 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03030920A1 *

Also Published As

Publication number Publication date
BR0213634A (pt) 2004-11-30
WO2003030920A1 (en) 2003-04-17
CN1564691A (zh) 2005-01-12
JP2005510477A (ja) 2005-04-21
WO2003030920A9 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
EP0797435B1 (en) Controlled release matrix for pharmaceuticals
AU2002314515B2 (en) Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
US20090124702A1 (en) Pharmaceutical Compositions of Metformin
US20060088594A1 (en) Highly compressible controlled delivery compositions of metformin
WO2009034541A9 (en) Controlled release pharmaceutical dosage forms of trimetazidine
AU2002314515A1 (en) Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
JPH07215843A (ja) 生物学的付着性を有する徐放性薬理組成物
JPH061716A (ja) 活性成分の長期放出性を有する投薬形
EP1377276B1 (en) Timed pulse release composition
WO2006124421A1 (en) Extended release tablet
US11324707B2 (en) Abuse-deterrent dosage forms containing esketamine
US20030099710A1 (en) Granule modulating hydrogel system
CA2265661A1 (en) Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2.2oct-c-yl)acetonitrile monohydrochloride
US20030175353A1 (en) Oral controlled drug delivery system
WO2003030920A1 (en) An antispasmodic agent spaced drug delivery system
EP2010158B1 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
US20040265381A1 (en) Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
KR20050114921A (ko) 방출제어형 약제학적 조성물
US20040228918A1 (en) Granule modulating hydrogel system
WO2008050188A2 (en) Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
WO2006136927A1 (en) Extended release formulations comprising venlafaxine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040426

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/50 20060101ALI20070219BHEP

Ipc: A61K 31/221 20060101AFI20070219BHEP

RTI1 Title (correction)

Free format text: AN ANTISPASMODIC AGENT SPACED DRUG DELIVERY SYSTEM

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070717